• Users Online: 359
  • Print this page
  • Email this page
Year : 2021  |  Volume : 12  |  Issue : 3  |  Page : 371-375

Partial lipodystrophy of limbs in type 2 diabetes: A case report

Dia Care – Diabetes and Hormone Clinic, Ahmedabad, Gujarat, India

Correspondence Address:
Dr. Meet Shah
Dia Care – Diabetes and Hormone Clinic 1 & 2 Gandhi Park, Near Nehrunagar Cross Roads, Ambawadi, Ahmedabad 380015, Gujarat.
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/JOD.JOD_15_21

Rights and Permissions

Rationale: On account of the diversity and rarity of lipodystrophy, this condition may be frequently unrecognized or misdiagnosed. This tends to be concerning as it is progressive and has potentially life-threatening complications. Patient Concerns: The patient was referred to our clinic with chief complaints of uncontrolled glycemia and an increased frequency of urination since last 3 months. The patient complained of weakness that led to thinning of upper limb muscles, loss of fat from face, neck, and upper thorax with simultaneous increase in abdominal girth, flattening of buttocks, and reduction in girth of lower limb muscles. Diagnosis: The patient was diagnosed with partial lipodystrophy of limbs (PLL) based on unique clinical features, blood investigations, and a DEXA fat scan. Interventions: The patient was treated with basal insulin glargine, metformin 1.5 g, dapagliflozin 10 mg, pioglitazone 7.5 mg, and atorvastatin 40 mg. He was vigorously educated to follow a strict diet and an exercise plan with necessary lifestyle modifications. Outcomes: After 3 months, the patient achieved better glycemic control with a reduction in HbA1c from 9.5% to 7.2%, as well as an improvement in lipid profile. He additionally achieved a weight reduction of 12 kg, with reduction in his abdominal girth from 130 to 118 cm. Lessons: The recognition of PLL in patients with type 2 diabetes can help better clinical management by alerting physicians to the associated comorbidities. Many a times, PLL goes unnoticed on account of the slow progression. Our case highlights the need for greater recognition of PLL as it has specific metabolic features that help in guiding appropriate clinical management.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded36    
    Comments [Add]    

Recommend this journal